-
1
-
-
0028053523
-
Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: Intra-arterial iodine-131-iodized oil versus medical support
-
Raoul JL, Guyader D, Bretagne JF, et al. Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support. J Nucl Med 1994;35:1782-7.
-
(1994)
J Nucl Med
, vol.35
, pp. 1782-1787
-
-
Raoul, J.L.1
Guyader, D.2
Bretagne, J.F.3
-
2
-
-
15644382890
-
The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study
-
Lee HS, Kim JS, Choi IJ, et al. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study. Cancer (Phila) 1997;79:2087-94.
-
(1997)
Cancer (Phila)
, vol.79
, pp. 2087-2094
-
-
Lee, H.S.1
Kim, J.S.2
Choi, I.J.3
-
3
-
-
0029952414
-
Implications of surgical treatment for advanced hepatocellular carcinoma with tumor thrombi in the portal vein
-
Tanaka A, Morimoto T, Yamaoka Y. Implications of surgical treatment for advanced hepatocellular carcinoma with tumor thrombi in the portal vein. Hepatogastroenterology 1996;43:637-43.
-
(1996)
Hepatogastroenterology
, vol.43
, pp. 637-643
-
-
Tanaka, A.1
Morimoto, T.2
Yamaoka, Y.3
-
4
-
-
0031911767
-
Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastasis: Proposal as a standard therapy
-
Ikai I, Yamaoka Y, Yamamoto Y, et al. Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastasis: proposal as a standard therapy. Ann Surg 1998;227:433-9.
-
(1998)
Ann Surg
, vol.227
, pp. 433-439
-
-
Ikai, I.1
Yamaoka, Y.2
Yamamoto, Y.3
-
5
-
-
0037080269
-
Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches
-
Sakon M, Nagano H, Dono K, et al. Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches. Cancer (Phila) 2002;94:435-42.
-
(2002)
Cancer (Phila)
, vol.94
, pp. 435-442
-
-
Sakon, M.1
Nagano, H.2
Dono, K.3
-
6
-
-
0027433529
-
Low serum alpha-fetoprotein level in patients with hepatocellular carcinoma as a predictor of response to 5-FU and interferon-alpha-2b
-
Patt YZ, Yoffe B, Charnsangavej C, et al. Low serum alpha-fetoprotein level in patients with hepatocellular carcinoma as a predictor of response to 5-FU and interferon-alpha-2b. Cancer (Phila) 1993;72:2574-82.
-
(1993)
Cancer (Phila)
, vol.72
, pp. 2574-2582
-
-
Patt, Y.Z.1
Yoffe, B.2
Charnsangavej, C.3
-
7
-
-
0030853192
-
Adaptor-tagged competitive PCR: A novel method for measuring relative gene expression
-
Kato K. Adaptor-tagged competitive PCR: a novel method for measuring relative gene expression. Nucleic Acids Res 1997;25:4694-6.
-
(1997)
Nucleic Acids Res
, vol.25
, pp. 4694-4696
-
-
Kato, K.1
-
8
-
-
0020396015
-
Toxicity and response criteria of the Eastern Cooperative Oncology Group
-
Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-55.
-
(1982)
Am J Clin Oncol
, vol.5
, pp. 649-655
-
-
Oken, M.M.1
Creech, R.H.2
Tormey, D.C.3
-
9
-
-
0033992317
-
Gene expression in mouse cerebellum during its development
-
Matoba R, Kato K, Saito S, et al. Gene expression in mouse cerebellum during its development. Gene (Amst) 2000;241:125-31.
-
(2000)
Gene (Amst)
, vol.241
, pp. 125-131
-
-
Matoba, R.1
Kato, K.2
Saito, S.3
-
10
-
-
0034005593
-
Correlation between gene functions and developmental expression patterns in the mouse cerebellum
-
Matoba R, Kato K, Kurooka C, et al. Correlation between gene functions and developmental expression patterns in the mouse cerebellum. Eur J Neurosci 2000;12:1357-71.
-
(2000)
Eur J Neurosci
, vol.12
, pp. 1357-1371
-
-
Matoba, R.1
Kato, K.2
Kurooka, C.3
-
11
-
-
0346874203
-
Molecular features of non-B, non-C hepatocellular carcinoma: A PCR-array gene expression profiling study
-
Kurokawa Y, Matoba R, Takemasa I, et al. Molecular features of non-B, non-C hepatocellular carcinoma: a PCR-array gene expression profiling study. J Hepatol 2003;39:1007-15.
-
(2003)
J Hepatol
, vol.39
, pp. 1007-1015
-
-
Kurokawa, Y.1
Matoba, R.2
Takemasa, I.3
-
12
-
-
11144356800
-
PCR-array gene expression profiling of hepatocellular carcinoma
-
Kurokawa Y, Matoba R, Nakamori S, et al. PCR-array gene expression profiling of hepatocellular carcinoma. J Exp Clin Cancer Res 2004;23:135-41.
-
(2004)
J Exp Clin Cancer Res
, vol.23
, pp. 135-141
-
-
Kurokawa, Y.1
Matoba, R.2
Nakamori, S.3
-
13
-
-
4444286417
-
Molecular-based prediction of early recurrence in hepatocellular carcinoma
-
Kurokawa Y, Matoba R, Takemasa I, et al. Molecular-based prediction of early recurrence in hepatocellular carcinoma. J Hepatol 2004;41:284-91.
-
(2004)
J Hepatol
, vol.41
, pp. 284-291
-
-
Kurokawa, Y.1
Matoba, R.2
Takemasa, I.3
-
14
-
-
0037081785
-
Molecular classification of primary breast tumors possessing distinct prognostic properties
-
Iwao K, Matoba R, Ueno N, et al. Molecular classification of primary breast tumors possessing distinct prognostic properties. Hum Mol Genet 2002;11:199-206.
-
(2002)
Hum Mol Genet
, vol.11
, pp. 199-206
-
-
Iwao, K.1
Matoba, R.2
Ueno, N.3
-
15
-
-
4644364404
-
Identification of expressed genes linked to malignancy of human colorectal carcinoma by parametric clustering of quantitative expression data
-
Muro S, Takemasa I, Oba S, et al. Identification of expressed genes linked to malignancy of human colorectal carcinoma by parametric clustering of quantitative expression data. Genome Biol http://genome-biology.com/2003/4/3/ R21.
-
Genome Biol
-
-
Muro, S.1
Takemasa, I.2
Oba, S.3
-
16
-
-
0033569406
-
Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring
-
Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science (Wash DC) 1999;286:531-7.
-
(1999)
Science (Wash DC)
, vol.286
, pp. 531-537
-
-
Golub, T.R.1
Slonim, D.K.2
Tamayo, P.3
-
17
-
-
0034794796
-
Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease
-
MacDonald TJ, Brown KM, LaFleur B, et al. Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nat Genet 2001;29:143-52.
-
(2001)
Nat Genet
, vol.29
, pp. 143-152
-
-
MacDonald, T.J.1
Brown, K.M.2
LaFleur, B.3
-
18
-
-
0037165140
-
Prediction of central nervous system embryonal tumor outcome based on gene expression
-
Pomeroy SL, Tamayo P, Gaasenbeek M, et al. Prediction of central nervous system embryonal tumor outcome based on gene expression. Nature (Lond) 2002;415:436-42.
-
(2002)
Nature (Lond)
, vol.415
, pp. 436-442
-
-
Pomeroy, S.L.1
Tamayo, P.2
Gaasenbeek, M.3
-
19
-
-
18544375333
-
MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia
-
Armstrong SA, Staunton JE, Silverman LB, et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 2002;30:41-7.
-
(2002)
Nat Genet
, vol.30
, pp. 41-47
-
-
Armstrong, S.A.1
Staunton, J.E.2
Silverman, L.B.3
-
21
-
-
0042125511
-
Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer
-
Chang JC, Wooten EC, Tsimelzon A, et al. Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer. Lancet 2003;362:362-9.
-
(2003)
Lancet
, vol.362
, pp. 362-369
-
-
Chang, J.C.1
Wooten, E.C.2
Tsimelzon, A.3
-
22
-
-
0035942271
-
Significance analysis of microarrays applied to the ionizing radiation response
-
Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001;98:5116-21.
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 5116-5121
-
-
Tusher, V.G.1
Tibshirani, R.2
Chu, G.3
-
23
-
-
0042424602
-
Statistical significance for genomewide studies
-
Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA 2003;100:9440-5.
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 9440-9445
-
-
Storey, J.D.1
Tibshirani, R.2
-
24
-
-
17544380855
-
Clinical significance of hepatic resection in hepatocellular carcinoma
-
Sakon M, Umeshita K, Nagano H, et al. Clinical significance of hepatic resection in hepatocellular carcinoma. Arch Surg 2000;135:1456-9.
-
(2000)
Arch Surg
, vol.135
, pp. 1456-1459
-
-
Sakon, M.1
Umeshita, K.2
Nagano, H.3
-
25
-
-
0036096420
-
Hepatocellular carcinoma: Diagnosis and treatment
-
Befeler AS, Di Bisceglie AM. Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 2002;122:1609-19.
-
(2002)
Gastroenterology
, vol.122
, pp. 1609-1619
-
-
Befeler, A.S.1
Di Bisceglie, A.M.2
-
26
-
-
0028965102
-
Hepatic resection for hepatocellular carcinoma. An audit of 343 patients
-
Lai EC, Fan ST, Lo CM, et al. Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg 1995;221:291-8.
-
(1995)
Ann Surg
, vol.221
, pp. 291-298
-
-
Lai, E.C.1
Fan, S.T.2
Lo, C.M.3
-
27
-
-
0034941503
-
Improving survival results after resection of hepatocellular carcinoma: A prospective study of 377 patients over 10 years
-
Poon RT, Fan ST, Lo CM, et al. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 2001;234:63-70.
-
(2001)
Ann Surg
, vol.234
, pp. 63-70
-
-
Poon, R.T.1
Fan, S.T.2
Lo, C.M.3
-
28
-
-
0035876465
-
Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients: Metaanalysis of three randomized controlled trials
-
Ono T, Yamanoi A, Nazmy EI, et al. Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients: metaanalysis of three randomized controlled trials. Cancer (Phila) 2001;91:2378-85.
-
(2001)
Cancer (Phila)
, vol.91
, pp. 2378-2385
-
-
Ono, T.1
Yamanoi, A.2
Nazmy, E.I.3
-
29
-
-
18544365698
-
Gene-expression profiles predict survival of patients with lung adenocarcinoma
-
Beer DG, Kardia SL, Huang CC, et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 2002;8:816-24.
-
(2002)
Nat Med
, vol.8
, pp. 816-824
-
-
Beer, D.G.1
Kardia, S.L.2
Huang, C.C.3
-
30
-
-
0037142053
-
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
-
Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002;346:1937-47.
-
(2002)
N Engl J Med
, vol.346
, pp. 1937-1947
-
-
Rosenwald, A.1
Wright, G.2
Chan, W.C.3
-
31
-
-
0037137519
-
A gene-expression signature as a predictor of survival in breast cancer
-
van de Vijver MJ, He YD, van't Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002;347:1999-2009.
-
(2002)
N Engl J Med
, vol.347
, pp. 1999-2009
-
-
Van De Vijver, M.J.1
He, Y.D.2
Van't Veer, L.J.3
-
32
-
-
0037177855
-
Transcript abundance in yeast varies over six orders of magnitude
-
Holland MJ. Transcript abundance in yeast varies over six orders of magnitude. J Biol Chem 2002;277:14363-6.
-
(2002)
J Biol Chem
, vol.277
, pp. 14363-14366
-
-
Holland, M.J.1
-
33
-
-
0032905998
-
Paclitaxel steady-state plasma concentration as a determinant of disease outcome and toxicity in lung cancer patients treated with paclitaxel and cisplatin
-
Rowinsky EK, Jiroutek M, Bonomi P, Johnson D, Baker SD. Paclitaxel steady-state plasma concentration as a determinant of disease outcome and toxicity in lung cancer patients treated with paclitaxel and cisplatin. Clin Cancer Res 1999;5:767-74.
-
(1999)
Clin Cancer Res
, vol.5
, pp. 767-774
-
-
Rowinsky, E.K.1
Jiroutek, M.2
Bonomi, P.3
Johnson, D.4
Baker, S.D.5
-
34
-
-
0037990003
-
Methylenetetra-hydrofolate reductase polymorphism in advanced colorectal cancer: A novel genomic predictor of clinical response to fluoropyrimidine-based chemotherapy
-
Cohen V, Panel-Raymond V, Sabbaghian N, et al. Methylenetetra-hydrofolate reductase polymorphism in advanced colorectal cancer: a novel genomic predictor of clinical response to fluoropyrimidine-based chemotherapy. Clin Cancer Res 2003;9:1611-5.
-
(2003)
Clin Cancer Res
, vol.9
, pp. 1611-1615
-
-
Cohen, V.1
Panel-Raymond, V.2
Sabbaghian, N.3
-
35
-
-
0033796587
-
A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs
-
Eichhorst ST, Muller M, Li-Weber M, et al. A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs. Mol Cell Biol 2000;20:7826-37.
-
(2000)
Mol Cell Biol
, vol.20
, pp. 7826-7837
-
-
Eichhorst, S.T.1
Muller, M.2
Li-Weber, M.3
-
36
-
-
0036300989
-
The predictive value of bcl-2, bax, bcl-xL, bag-1, fas, and fasL for chemotherapy response in advanced breast cancer
-
Sjostrom J, Blomqvist C, von Boguslawski K, et al. The predictive value of bcl-2, bax, bcl-xL, bag-1, fas, and fasL for chemotherapy response in advanced breast cancer. Clin Cancer Res 2002;8:811-6.
-
(2002)
Clin Cancer Res
, vol.8
, pp. 811-816
-
-
Sjostrom, J.1
Blomqvist, C.2
Von Boguslawski, K.3
-
37
-
-
0034971588
-
Reduction in matrix metalloproteinase production by tendon and synovial fibroblasts after a single exposure to 5-fluorouracil
-
Ragoowansi R, Khan U, Brown RA, McGrouther DA. Reduction in matrix metalloproteinase production by tendon and synovial fibroblasts after a single exposure to 5-fluorouracil. Br J Plast Surg 2001;54:283-7.
-
(2001)
Br J Plast Surg
, vol.54
, pp. 283-287
-
-
Ragoowansi, R.1
Khan, U.2
Brown, R.A.3
McGrouther, D.A.4
-
38
-
-
0034655105
-
19F magnetic resonance spectroscopy in vivo predict response of murine RIF-1 tumors to 5-fluorouracil
-
19F magnetic resonance spectroscopy in vivo predict response of murine RIF-1 tumors to 5-fluorouracil. Cancer Res 2000;60:2122-7.
-
(2000)
Cancer Res
, vol.60
, pp. 2122-2127
-
-
McSheehy, P.M.1
Leach, M.O.2
Judson, I.R.3
Griffiths, J.R.4
-
39
-
-
0032530089
-
p59OASL, a 2′-5′ oligoadenylate synthetase like protein: A novel human gene related to the 2′-5′ oligoadenylate synthetase family
-
Hartmann R, Olsen HS, Widder S, Jorgensen R, Justesen J. p59OASL, a 2′-5′ oligoadenylate synthetase like protein: a novel human gene related to the 2′-5′ oligoadenylate synthetase family. Nucleic Acids Res 1998;26:4121-8.
-
(1998)
Nucleic Acids Res
, vol.26
, pp. 4121-4128
-
-
Hartmann, R.1
Olsen, H.S.2
Widder, S.3
Jorgensen, R.4
Justesen, J.5
-
40
-
-
0038239253
-
Characterization of the 2′-5′-oligoadenylate synthetase ubiquitin-like family
-
Eskildsen S, Justesen J, Schierup MH, Hartmann R. Characterization of the 2′-5′-oligoadenylate synthetase ubiquitin-like family. Nucleic Acids Res 2003;31:3166-73.
-
(2003)
Nucleic Acids Res
, vol.31
, pp. 3166-3173
-
-
Eskildsen, S.1
Justesen, J.2
Schierup, M.H.3
Hartmann, R.4
-
41
-
-
0037790592
-
Apoptosis and interferons: Role of interferon-stimulated genes as mediators of apoptosis
-
Chawla-Sarkar M, Lindner DJ, Liu YF, et al. Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 2003;8:237-49.
-
(2003)
Apoptosis
, vol.8
, pp. 237-249
-
-
Chawla-Sarkar, M.1
Lindner, D.J.2
Liu, Y.F.3
-
42
-
-
0025360452
-
Antiproliferative and antitumor effects of alpha-interferon in renal cell carcinomas: Correlation with the expression of a kidney-associated differentiation glycoprotein
-
Nanus DM, Pfeffer LM, Bander NH, Bahri S, Albino AP. Antiproliferative and antitumor effects of alpha-interferon in renal cell carcinomas: correlation with the expression of a kidney-associated differentiation glycoprotein. Cancer Res 1990;50:4190-4.
-
(1990)
Cancer Res
, vol.50
, pp. 4190-4194
-
-
Nanus, D.M.1
Pfeffer, L.M.2
Bander, N.H.3
Bahri, S.4
Albino, A.P.5
-
43
-
-
0025228386
-
Effect of calmodulin antagonists on the interferon system: Induction and action of interferons
-
Lin HY, Davis PJ, Davis FB, Chadha KC, Thacore HR. Effect of calmodulin antagonists on the interferon system: induction and action of interferons. J Interferon Res 1990;10:39-46.
-
(1990)
J Interferon Res
, vol.10
, pp. 39-46
-
-
Lin, H.Y.1
Davis, P.J.2
Davis, F.B.3
Chadha, K.C.4
Thacore, H.R.5
-
44
-
-
0021824119
-
Treatment of hepatocellular carcinoma with recombinant leucocyte interferon: A pilot study
-
Sachs E, Di Bisceglie AM, Dusheiko GM, et al. Treatment of hepatocellular carcinoma with recombinant leucocyte interferon: a pilot study. Br J Cancer 1985;52:105-9.
-
(1985)
Br J Cancer
, vol.52
, pp. 105-109
-
-
Sachs, E.1
Di Bisceglie, A.M.2
Dusheiko, G.M.3
|